Tractional retinal detachment after intravitreal injection of bevacizumab in proliferative diabetic retinopathy.

Purpose: To assess the short-term complications of a single dose of intravitreal bevacizumab in patients with proliferative diabetic retinopathy (PDR).

Methods: Retrospective review of 343 patients with PDR who were treated with intravitreal injection of bevacizumab (2.5 mg/0.

Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.

Purpose: To determine short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization (CNV) in pathologic myopia.

Methods: In this prospective interventional case series, patients were treated with 2.5 mg of intravitreal bevacizumab and followed for 3 months.